J-ENTRY CONSORTIUM Trademark

Trademark Overview


On Friday, January 24, 2025, a trademark application was filed for J-ENTRY CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the J-ENTRY CONSORTIUM trademark a serial number of 79420260. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 8, 2025. This trademark is owned by SANWA KAGAKU KENKYUSHO CO., LTD.. The J-ENTRY CONSORTIUM trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Marketing research and analysis services; marketing research and analysis services relating to pharmaceuticals; marketing services in the field of pharmaceuticals; market intelligence services; providing business information; providing business information via a website; business management assistance; business management planning; business enquiries and investigations; providing business information relating to sales of pharmaceuticals; business consultancy regarding productivity improvement of pharmaceuticals; negotiation and conclusion of commercial transactions for third parties; negotiation of business contracts for others; business partnership search in the nature of matching clients with business partners

Development of pharmaceutical products and providing information relating thereto; providing information about development of pharmaceutical products; scientific research in the nature of conducting clinical trials of pharmaceuticals for others and providing information relating thereto; pharmaceutical product evaluation; providing information via the Internet relating to pharmaceutical research; providing information about medical and scientific research in the field of pharmaceuticals; technical consultancy services in the field of pharmaceutical products development; research and provision of technical information in relation to pharmaceutical products development
j-entry consortium

General Information


Serial Number79420260
Word MarkJ-ENTRY CONSORTIUM
Filing DateFriday, January 24, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, December 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 30, 2025

Trademark Statements


Goods and ServicesMarketing research and analysis services; marketing research and analysis services relating to pharmaceuticals; marketing services in the field of pharmaceuticals; market intelligence services; providing business information; providing business information via a website; business management assistance; business management planning; business enquiries and investigations; providing business information relating to sales of pharmaceuticals; business consultancy regarding productivity improvement of pharmaceuticals; negotiation and conclusion of commercial transactions for third parties; negotiation of business contracts for others; business partnership search in the nature of matching clients with business partners
NOT AVAILABLE"CONSORTIUM"
Description of MarkThe mark consists of the stylized wording "J-ENTRY" above the stylized wording "CONSORTIUM" to the right of a design of four overlapping quadrilaterals of various sizes with curved corners.
Pseudo MarkJ ENTRY CONSORTIUM
Goods and ServicesDevelopment of pharmaceutical products and providing information relating thereto; providing information about development of pharmaceutical products; scientific research in the nature of conducting clinical trials of pharmaceuticals for others and providing information relating thereto; pharmaceutical product evaluation; providing information via the Internet relating to pharmaceutical research; providing information about medical and scientific research in the field of pharmaceuticals; technical consultancy services in the field of pharmaceutical products development; research and provision of technical information in relation to pharmaceutical products development

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, March 28, 2025
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 28, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANWA KAGAKU KENKYUSHO CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, March 27, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 28, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sunday, March 30, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 30, 2025APPLICATION FILING RECEIPT MAILED
Sunday, July 6, 2025ASSIGNED TO EXAMINER
Saturday, July 19, 2025NON-FINAL ACTION WRITTEN
Sunday, July 20, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, August 22, 2025REFUSAL PROCESSED BY MPU
Friday, August 22, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 12, 2025REFUSAL PROCESSED BY IB
Monday, December 1, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 9, 2025NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 10, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 24, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 25, 2025NOTIFICATION PROCESSED BY IB